心血管损伤的分子影像研究进展  

Research progress on molecular imaging in cardiovascular injury

作　　者：周钰程 方岩 曹丰[2] Chou Yucheng;Fang Yan;Cao Feng(School of Medicine,Nankai University,Tianjin 300071,China;Institute of Geriatric Medicine,National Clinical Research Center for Geriatric Diseases,the Second Medical Center,Chinese PLA General Hospital,Beijing 100853,China)

机构地区：[1]南开大学医学院,天津300071 [2]解放军总医院第二医学中心老年医学研究所,国家老年疾病临床医学研究中心,北京100853

出　　处：《中国心血管杂志》2025年第2期138-142,共5页Chinese Journal of Cardiovascular Medicine

基　　金：国家重点研发计划(2022YFA1104504、2022YFC3602400);北京市自然科学基金(L241026);中央保健科研重点课题(2020ZD05)。

摘　　要：分子影像是心血管疾病精准诊疗的重要手段,结合纳米材料可实现损伤发生与发展的分子层面可视化。随着研究深入,靶向纳米载药系统有望实现心血管疾病的诊疗一体化。尽管当前纳米分子探针仍面临挑战,但借助人工智能与新材料的开发,分子影像展现出广阔的临床应用前景。Molecular imaging serves as a critical approach for the precise diagnosis and treatment of cardiovascular diseases.By integrating nanomaterials,it enables the visualization of cardiovascular injury at the molecular level during its onset and progression.With further advancements in research within this field,targeted nano drug delivery systems are anticipated to achieve integrated diagnosis and therapy for cardiovascular diseases.Although current nano-scale molecular probes still face considerable challenges,the development of artificial intelligence and novel materials has demonstrated broad prospects for the clinical application of molecular imaging.

关 键 词：心血管疾病 分子影像 多模态成像 

分 类 号：R54[医药卫生—心血管疾病]